PCM
HITK

Prelude Capital Management’s HI-TECH PHARMACAL INC HITK Stock Holding History

Prelude Capital Management’s Portfolio HITK Stock Details HITK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-22,282
Closed -$965K – 2453
2014
Q1 		$965K Buy
22,282
+7,282
+49% +$316K 0.13% 194
2013
Q4 		$651K Hold
15,000
– – 0.11% 266
2013
Q3 		$647K Buy
+15,000
New +$574K 0.1% 233

Prelude Capital Management's HITK Position: Q2 2014 in Review

Prelude Capital Management sold out of HI-TECH PHARMACAL INC (HITK) in Q2 2014, closing a stake of 22,282 shares — an estimated $965K sold.

Prelude Capital Management first reported a position in HITK in Q3 2013 and held it in 3 quarters. The position peaked at $965K in Q1 2014. 0 funds tracked by Wall St. Rank hold HITK as of Q2 2014.

  • Prelude Capital Management reported no remaining HI-TECH PHARMACAL INC position as of Q2 2014 after selling out during the quarter.
  • Prelude Capital Management sold 22,282 HI-TECH PHARMACAL INC shares in Q2 2014, an estimated $965K.
  • Prelude Capital Management first reported a position in HI-TECH PHARMACAL INC in Q3 2013 and held it in 3 quarters.
  • Prelude Capital Management's HI-TECH PHARMACAL INC position peaked at $965K in Q1 2014.
  • 0 funds tracked by Wall St. Rank held HI-TECH PHARMACAL INC as of Q2 2014.

Based on Prelude Capital Management's 13F filing for Q2 2014, filed 14 Aug 2014.